Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GSK presents novel compounds for the treatment of anemia

Dec. 29, 2009

Ligand obtains positive regulatory opinion in Europe for Revolade

Dec. 28, 2009

Arena submits NDA to FDA for lorcaserin for weight management

Dec. 28, 2009

Wellstat Therapeutics developing URAT1 inhibitors for the treatment of gout

Dec. 28, 2009

Vitae Pharmaceuticals and Boehringer Ingelheim claim novel antiobesity agents

Dec. 28, 2009

Roche discloses CPT-2 inhibitors for the treatment of type 2 diabetes

Dec. 28, 2009

Shire submits BLA to the FDA for Replagal, updates Gaucher disease therapy

Dec. 28, 2009

EMEA recommends withdrawal of benfluorex from the market in E.U.

Dec. 28, 2009

PDL and Lilly sign license agreement for teplizumab and other anti-CD3 molecules

Dec. 24, 2009

CPEX completes enrollment in phase IIa Nasulin trial

Dec. 24, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...